Exelixis
EXEL
633 hedge funds and large institutions have $11.2B invested in Exelixis in 2025 Q2 according to their latest regulatory filings, with 124 funds opening new positions, 235 increasing their positions, 214 reducing their positions, and 42 closing their positions.
195% more first-time investments, than exits
New positions opened: 124 | Existing positions closed: 42
20% more capital invested
Capital invested by funds: $9.38B → $11.2B (+$1.85B)
14% more funds holding
Funds holding: 557 → 633 (+76)
2.64% more ownership
Funds ownership: 90.86% → 93.5% (+2.6%)
10% more repeat investments, than reductions
Existing positions increased: 235 | Existing positions reduced: 214
7% more call options, than puts
Call options by funds: $82.8M | Put options by funds: $77.6M
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$66.6M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$63.2M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$52M |
| 4 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$50M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$260M |
| 2 |
Two Sigma Advisers
New York
|
-$74.2M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$60.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$48.1M |
| 5 |
Two Sigma Investments
New York
|
-$38.3M |
EXEL Hedge Fund Activity: Q2 2025 in Review
633 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2025, worth a combined $11.2B — up 20% from $9.38B a quarter earlier.
Buyers outnumbered sellers: 124 funds opened new EXEL positions and 42 closed out — a net gain of 82 holders — while 235 added to existing stakes and 214 trimmed.
The largest buyer was Qube Research & Technologies (QRT), adding an estimated $66.6M. The largest seller was Farallon Capital Management, cutting an estimated $260M.
- 633 institutional investors held Exelixis (EXEL) as of Q2 2025, up from 557 in Q1 2025.
- Funds reported $11.2B of Exelixis stock for Q2 2025, up 20% quarter-over-quarter.
- 124 funds opened new Exelixis positions in Q2 2025 and 42 closed out, a net change of +82 holders.
- The largest Exelixis buyer in Q2 2025 was Qube Research & Technologies (QRT), an estimated $66.6M added.
- The largest Exelixis seller in Q2 2025 was Farallon Capital Management, an estimated $260M sold.
Based on aggregated 13F filings for Q2 2025.